Neo Ivy Capital Management Bristol Myers Squibb CO Transaction History

Neo Ivy Capital Management

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$63.71 - $70.74 $19,495 - $21,646	-306 Reduced 2.28%	13,098 $837,000
Q4 2022 Mar 24, 2023	BUY	$68.48 - $81.09 $917,905 - $1.09 Million	13,404 New	13,404 $964,000
Q2 2022 Aug 16, 2022	SELL	$72.62 - $79.98 $353,804 - $389,662	-4,872 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $182,288 - $218,579	2,965 Added 155.48%	4,872 $356,000
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $102,272 - $119,225	1,907 New	1,907 $118,000
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $117,195 - $127,626	-1,893 Closed	0 $0
Q1 2021 Oct 07, 2021	BUY	$59.34 - $66.74 $112,330 - $126,338	1,893 New	1,893 $120,000
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $461,862 - $523,374	-7,999 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$57.43 - $63.64 $1.38 Million - $1.52 Million	-23,951 Reduced 74.96%	7,999 $482,000
Q2 2020 Aug 17, 2020	BUY	$54.82 - $64.09 $1.68 Million - $1.96 Million	30,597 Added 2261.42%	31,950 $1.88 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $62,779 - $91,232	1,353 New	1,353 $75,000
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $30,559 - $39,861	-621 Closed	0 $0
Q3 2019 Nov 21, 2019	SELL	$42.77 - $50.71 $1.34 Million - $1.59 Million	-31,329 Reduced 98.06%	621 $30,000
Q2 2019 Aug 15, 2019	BUY	$44.62 - $49.34 $614,015 - $678,967	13,761 Added 75.66%	31,950 $1.45 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $820,687 - $978,568	18,189 New	18,189 $867,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.